Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii

American Journal of Infection Control

Volumn 43, Issue 8, 2015, Pages 857-860

  Fu, Qiang ^a   Ye, Huan ^a   Liu, Shumei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; Bacteremia; Extensive drug resistance; Geriatric inpatients; Risk factors

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PENICILLIN DERIVATIVE; POLYMYXIN; QUINOLONE DERIVATIVE; SULTAMICILLIN; TETRACYCLINE DERIVATIVE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCURRENT INFECTION; EXTENSIVE DRUG RESISTANCE ACINETOBACTER BAUMANNII; FEMALE; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; IMMOBILITY; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; RETROSPECTIVE STUDY; VERY ELDERLY; ACINETOBACTER INFECTIONS; AGE; BACTEREMIA; COINFECTION; DRUG EFFECTS; HOSPITAL PATIENT; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; RISK FACTOR; SURVIVAL ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTEREMIA; CHINA; COINFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INCIDENCE; INPATIENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84938288872     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.03.033     Document Type: Article

References (14)

1. A.Y. Peleg, H. Seifert, and D.L. Paterson Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 2008 538 582
2. J. Vila, and J. Pachon Therapeutic options for Acinetobacter baumannii infections: an update Expert Opin Pharmacother 13 2012 2319 2336
3. I. Abbott, G.M. Cerqueira, S. Bhuiyan, and A.Y. Peleg Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies Expert Rev Anti Infect Ther 11 2013 395 409
4. S.Y. Park, J.W. Choo, S.H. Kwon, S.N. Yu, E.J. Lee, T.H. Kim, and et al. Risk factors for mortality in patients with Acinetobacter baumannii bacteremia Infect Chemother 45 2013 325 330
5. W.H. Sheng, C.H. Liao, T.L. Lauderdale, W.C. Ko, Y.S. Chen, J.W. Liu, and et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii Int J Infect Dis 14 2010 e764 e769
6. T. Chopra, D. Marchaim, R.A. Awali, A. Krishna, P. Johnson, R. Tansek, and et al. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes Antimicrobial Agents Chemother 57 2013 6270 6275
7. S. Anunnatsiri, and P. Tonsawan Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand Southeast Asian J Trop Med Public Health 42 2011 693 703
8. S.T. Huang, M.C. Chiang, S.C. Kuo, Y.T. Lee, T.H. Chiang, S.P. Yang, and et al. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia J Microbiol Immunol Infect 45 2012 356 362
9. E.V. Lemos, F.P. De la Hoz, T.R. Einarson, W.F. McGhan, E. Quevedo, C. Castañeda, and et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis Clin Microbiol Infect 20 2014 416 423
10. F. Cockerill, M. Wikler, K. Bush, M. Dudley, G. Eliopoulos, D. Hardy, and et al. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. M100-S20 2010 Clinical Laboratory Standards Institute Wayne [PA]
11. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, C.G. Giske, and et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268 281
12. C. Routsi, M. Pratikaki, E. Platsouka, C. Sotiropoulou, S. Nanas, V. Markaki, and et al. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes Infection 38 2010 173 180
13. T.M. Ng, C.B. Teng, D.C. Lye, and A. Apisarnthanarak A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia Infect Control Hosp Epidemiol 35 2014 49 55
14. E.S. Özgür, E.S. Horasan, K. Karaca, G. Ersöz, S. NaycI AtIş, and A. Kaya Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes Am J Infect Control 42 2014 206 208